Endonovo Therapeutics Inc (ENDV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENDV | AMGN | GILD | BIIB | CELG |
| Company | Endonovo Therapeutics Inc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0027 | 264.63 | 66.25 | 190.72 | 108.01 |
| High | 0.0027 | 269.38 | 66.83 | 194.52 | 108.59 |
| Low | 0.0026 | 260.68 | 66.16 | 189.44 | 107.27 |
| Last | 0.0026 | 268.93 | 66.76 | 194.38 | 108.24 |
| Change | -0.0002 | +6.18 | +0.60 | +3.86 | +0.11 |
| % Change | -7.14% | +2.35% | +0.91% | +2.03% | +0.10% |
| Volume | 45,300 | 3,380,300 | 10,657,000 | 1,599,700 | 191,230,496 |
| 20-Day Average Volume | 3,092,065 | 2,246,435 | 6,455,920 | 1,141,000 | 16,188,930 |
| Previous Close | 0.0028 | 262.75 | 66.16 | 190.52 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 0.0028 | 272.56 | 69.90 | 205.03 | 108.17 |
| 20-Day Raw Stochastic | 15.79% | 29.59% | 10.79% | 15.51% | 63.25% |
| 20-Day Relative Strength | 45.57% | 43.95% | 31.30% | 32.40% | 64.69% |
| Weighted Alpha | -82.09 | +7.67 | -24.32 | -36.99 | +46.30 |
| Today's Opinion | 100% Sell | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Previous Opinion | 96% Sell | 56% Sell | 100% Sell | 100% Sell | 100% Buy |
| Last Month's Opinion | 100% Sell | 8% Sell | 72% Sell | 100% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | unch since 04/10/24 | +0.62% since 04/12/24 | -1.92% since 04/12/24 | -1.92% since 04/12/24 | -1.97% since 11/13/19 |
| Low | 0.0024 on 04/17/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 107.27 on 11/20/19 |
| High | 0.0033 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 199.53 on 04/15/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | -27.78% since 03/19/24 | -1.03% since 03/19/24 | -9.06% since 03/19/24 | -11.09% since 03/19/24 | +5.14% since 10/18/19 |
| Low | 0.0020 on 03/27/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 102.40 on 10/21/19 |
| High | 0.0058 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 221.74 on 03/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | -70.79% since 01/19/24 | -12.63% since 01/19/24 | -23.52% since 01/19/24 | -22.24% since 01/19/24 | +13.63% since 08/20/19 |
| Low | 0.0010 on 02/07/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 93.41 on 08/23/19 |
| High | 0.0093 on 01/23/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 252.17 on 01/22/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | -81.43% since 10/19/23 | -4.16% since 10/19/23 | -14.89% since 10/19/23 | -24.45% since 10/19/23 | +14.14% since 05/20/19 |
| Low | 0.0010 on 02/07/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 0.0160 on 12/04/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 268.30 on 01/03/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 933 | 140,812,720 | 82,374,304 | 27,694,178 | 77,035,920 |
| Shares Outstanding, K | 333,038 | 535,919 | 1,245,077 | 145,361 | 711,714 |
| Annual Sales | 140,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | -18,470,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 50,000 | 8,196,000,000 | 7,114,000,000 | 2,386,300,000 | 4,520,000,000 |
| Last Quarter Net Income | 2,060,000 | 767,000,000 | 1,429,000,000 | 249,700,000 | 1,691,000,000 |
| 60-Month Beta | -1.41 | 0.58 | 0.19 | -0.02 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.00 on 12/28/23 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 2.95 on 02/13/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 05/27/24 | 05/02/24 | 04/25/24 | 04/24/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 13.05 | 10.99 |